Coronavirus Response Update Part 1

Oracle Donates Therapeutic Learning System to HHS to Gather Crowd-Sourced Data on COVID-19 (HERE)

• HHS is announcing an ongoing partnership with Oracle, including Oracle’s donation to HHS of the Therapeutic Learning System, an online platform designed to collect real-time medical data related to COVID-19.

SAMHSA Moves Quickly to Begin Releasing $110 Million in Emergency Grant Funding to Provide Americans with Substance Use Treatment and Mental Health Services During the COVID-19 Pandemic (HERE)

• The Substance Abuse and Mental Health Services Administration has expedited its process to today release emergency grants to strengthen access to treatments for substance use disorders and serious mental illnesses during the COVID-19 pandemic.

The Path Forward: Coronavirus Treatment Acceleration Program (HERE)

• The coronavirus pandemic is an unprecedented event in modern history and has required an extraordinary response around the world…Quickly after the emergence of this virus, the U.S. Food and Drug Administration began working directly with federal health partners, academia and industry to advance medical countermeasures against COVID-19. Given the urgent nature of the pandemic, the FDA launched a new program called the Coronavirus Treatment Acceleration Program (CTAP) to move new treatments to patients as soon as possible, while at the same time finding out whether they are helpful or harmful. So far, 72 clinical trials of potential therapies for COVID-19 are underway with FDA oversight.